CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price traded up 5.9% during mid-day trading on Wednesday . The company traded as high as $66.13 and last traded at $66.00. 856,731 shares were traded during trading, a decline of 48% from the average session volume of 1,654,993 shares. The stock had previously closed at […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price traded up 5.9% during mid-day trading on Wednesday . The company traded as high as $66.13 and last traded at $66.00. 856,731 shares were traded during trading, a decline of 48% from the average session volume of 1,654,993 shares. The stock had previously closed at […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) CFO Leslie D. Funtleyder sold 16,980 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $4.32, for a total transaction of $73,353.60. Following the completion of the sale, the chief financial officer now owns 291,441 shares […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) insider Riccardo Perfetti sold 22,003 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $4.32, for a total transaction of $95,052.96. Following the sale, the insider now owns 1,009,534 shares of the company’s stock, valued at […]
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 11,340,000 shares, an increase of 11.8% from the April 30th total of 10,140,000 shares. Based on an average daily trading volume, of 1,930,000 […]